BMEA
Biomea Fusion, Inc. · Healthcare
A2A Pharmaceuticals, Inc. bought $380K of Biomea Fusion, Inc.
10% owner
Bought$379,852
$10.96Price
34,658Shares
+1%Stake
What BMEA did for a copier
- $1,000 copied at Tue, Sep 21 close, $10.00
- $1,064
- S&P 500, same days
- +6.5%
Measured over 30 trading days, to the Nov 2 close.
A2A Pharmaceuticals, Inc.'s record
1 other buy on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Sep 17. Filed Tue, Sep 21, 12:05 PM ET, during the session. Returns use the Sep 21 close and the Nov 2 close. Not investment advice.